BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7363464)

  • 21. [Clinical value of serum prostatic acid phosphatase determined by radioimmunoassay (author's transl)].
    Machida T; Miki M; Ohishi Y; Ueda M; Kido A; Yanagisawa M; Yoshida M
    Nihon Hinyokika Gakkai Zasshi; 1981 Apr; 72(4):416-22. PubMed ID: 6169864
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of prostatic acid phosphatase in the investigation and treatment of adenocarcinoma of the prostate.
    Bruce AW; Mahan DE
    Ann N Y Acad Sci; 1982; 390():110-21. PubMed ID: 6953923
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on the measurement of serum prostatic acid phosphatase with RIA-Quant PAP test kit (author's transl)].
    Kawamura J; Yoshida O; Kousaka T; Yoshii M; Morita R; Torizuka K
    Kaku Igaku; 1982 Mar; 19(2):313-22. PubMed ID: 7109329
    [No Abstract]   [Full Text] [Related]  

  • 24. Rapid radioimmunoassay for prostate-specific acid phosphatase in human serum.
    Vihko P; Kostama A; Jänne O; Sajanti E; Vihko R
    Clin Chem; 1980 Oct; 26(11):1544-7. PubMed ID: 6158382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunological colorimetric determination of serum prostatic acid phosphatase activity in patients with prostatic diseases comparing with RIA and Kind-King modified methods].
    Hayashi Y; Saionji K; Kitagawa R; Iizuka K; Higurashi H
    Rinsho Byori; 1985 Sep; 33(9):1031-40. PubMed ID: 3908752
    [No Abstract]   [Full Text] [Related]  

  • 26. Circadian and day-to-day variation of prostatic acid phosphatase.
    Nissenkorn I; Mickey DD; Miller DB; Soloway MS
    J Urol; 1982 Jun; 127(6):1122-4. PubMed ID: 6177878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current experience with radioimmunoassay techniques for prostatic acid phosphatase.
    Cooper JF; Finkle WD
    Prostate; 1980; 1(4):441-50. PubMed ID: 7279809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [What is the use of the radioimmunoassay of prostatic acid phosphatase?].
    Luckacs B; Cohen L; Coloby P; Gattegno B; Michel F; Agnes E; Roland J; Thibault P
    J Urol (Paris); 1985; 91(4):211-4. PubMed ID: 2410516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
    Morote Robles J; de Torres Mateos JA
    Arch Esp Urol; 1989; 42 Suppl 2():124-30. PubMed ID: 2484148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient high serum prostate-specific acid phosphatase measured by radioimmunoassay in prostatic infarction.
    Vihko P; Kontturi M
    Scand J Urol Nephrol; 1981; 15(3):213-4. PubMed ID: 7323740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radioimmunoassay kit for human prostate acid phosphatase--experimental and clinical evaluation of RIA-Quant P.A.P. Test Kit].
    Wakabayashi K; Sugiyama Y; Takahashi E; Shida K
    Kaku Igaku; 1982 Apr; 19(3):467-75. PubMed ID: 6182321
    [No Abstract]   [Full Text] [Related]  

  • 32. Radioimmunoassay of serum prostatic acid phosphatase in prostatic cancer.
    Br Med J; 1978 Sep; 2(6139):719-20. PubMed ID: 698693
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of serum prostatic acid phosphatase as a tumor marker in men with advanced adenocarcinoma of the prostate.
    Maatman TJ; Gupta MK; Montie JE
    J Urol; 1984 Jul; 132(1):58-60. PubMed ID: 6726962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of prostatic acid phosphatase in adenocarcinoma of the prostate.
    Bruce AW; Mahan DE; Sullivan LD; Goldenberg L
    J Urol; 1981 Mar; 125(3):357-60. PubMed ID: 6162968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-antibody immunoenzyme assay for human prostatic acid phosphatase.
    Choe BK; Pontes EJ; Dong MK; Rose NR
    Clin Chem; 1980 Dec; 26(13):1854-9. PubMed ID: 6159996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostatic acid phosphatase by radioimmunoassay. Sensitivity compared with enzymatic assay.
    Lindholm GR; Stirton S; Liedtke RJ; Batjer JD
    JAMA; 1980 Nov; 244(18):2071-3. PubMed ID: 6159488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoreactive prostate-specific acid phosphatase in prostatic cancer.
    Kontturi M; Vihko P; Lukkarinen O; Vihko R
    Scand J Clin Lab Invest Suppl; 1985; 179():67-74. PubMed ID: 3866311
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum prostate-specific acid phosphatase: development and validation of a specific radioimmunoassay.
    Vihko P; Sajanti E; Jänne O; Peltonen L; Vihko R
    Clin Chem; 1978 Nov; 24(11):1915-9. PubMed ID: 709820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early detection of prostatic cancer by radioimmunoassay for prostatic acid phosphatase.
    Med Lett Drugs Ther; 1979 Nov; 21(22):90-1. PubMed ID: 492069
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostatic acid phosphatase: comparison of radioimmunoassay and enzyme activity assay.
    Mensink HJ; Marrink J; Hindriks FR; van Zanten AK
    J Urol; 1983 Jun; 129(6):1136-40. PubMed ID: 6854787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.